Suppr超能文献

通过在免疫刺激复合物(ISCOMs)中用纯化的HIV-1包膜蛋白免疫诱导CD8 + 细胞毒性T细胞

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs.

作者信息

Takahashi H, Takeshita T, Morein B, Putney S, Germain R N, Berzofsky J A

机构信息

Molecular Immunogenetics and Vaccine Research Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Nature. 1990 Apr 26;344(6269):873-5. doi: 10.1038/344873a0.

Abstract

To reduce the risks of immunization with killed or live attenuated virus vaccines, it may be advantageous to use a pure, defined antigen that contains determinants for both humoral and cellular immunity. However, although most non-living intact protein preparations induce antibodies and CD4+ major histocompatibility complex (MHC) class II-restricted helper and/or cytotoxic T lymphocytes (CTL), they do not elicit CD8+ MHC class I restricted CTL. Indeed, with a few exceptions, it has not so far been possible to induce CD8+ CTL by immunizing with intact soluble proteins. We show here that a single subcutaneous immunization in mice with immunostimulating complexes containing either purified intact gp160 envelope glycoprotein of the human immunodeficiency virus (HIV)-1 or influenza haemagglutinin results in reproducible and long-lasting priming of HIV specific or influenza-specific CD8+, MHC class I restricted CTL.

摘要

为降低使用灭活或减毒活病毒疫苗进行免疫接种的风险,使用一种包含体液免疫和细胞免疫决定簇的纯的、明确的抗原有可能是有益的。然而,尽管大多数非活性完整蛋白制剂可诱导抗体以及CD4⁺主要组织相容性复合体(MHC)Ⅱ类限制性辅助性和/或细胞毒性T淋巴细胞(CTL),但它们不会引发CD8⁺MHCⅠ类限制性CTL。事实上,除了少数例外情况,迄今为止通过用完整的可溶性蛋白进行免疫接种来诱导CD8⁺CTL尚未成功。我们在此表明,在小鼠中单次皮下接种含有纯化的完整人类免疫缺陷病毒(HIV)-1包膜糖蛋白gp160或流感血凝素的免疫刺激复合物,可导致对HIV特异性或流感特异性CD8⁺、MHCⅠ类限制性CTL进行可重复且持久的致敏。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验